Setmelanotide, an MC4R Agonist, for Obesity in Individuals with Smith-Magenis Syndrome

Published: 26 April 2024| Version 1 | DOI: 10.17632/hxv6jxmp2j.1
Contributor:
Jack Yanovski

Description

Underlying data presented in manuscript titled, "Setmelanotide, an MC4R Agonist, for Obesity in Individuals with Smith-Magenis Syndrome"

Files

Steps to reproduce

See manuscript for analysis details.

Institutions

National Institute of Child Health and Human Development

Categories

Pharmacotherapy, Cholesterol, Body Weight, Body Fat Mass

Funding

Rhythm Pharmaceuticals

Licence